TY - JOUR
T1 - The Sulfated Steroids Pregnenolone Sulfate and Dehydroepiandrosterone Sulfate Inhibit the a1b3c2L GABAA Receptor by Stabilizing a Novel Nonconducting State
AU - Pierce, Spencer R.
AU - Germann, Allison L.
AU - Steinbach, Joe Henry
AU - Akk, Gustav
N1 - Publisher Copyright:
© 2022 by The American Society.
PY - 2022/2/1
Y1 - 2022/2/1
N2 - The GABAA receptor is inhibited by the endogenous sulfated steroids pregnenolone sulfate (PS) and dehydroepiandrosterone sulfate (DHEAS). It has been proposed in previous work that these steroids act by enhancing desensitization of the receptor. Here, we have investigated the modulatory effects of the steroids on the human a1b3c2L GABAA receptor. Using electrophysiology and quantitative model-based data analysis, we show that exposure to the steroid promotes occupancy of a nonconducting state that retains high affinity to the transmitter but whose properties differ from those of the classic, transmitter-induced desensitized state. From the analysis of the inhibitory actions of two combined steroids, we infer that PS and DHEAS act through shared or overlapping binding sites.
AB - The GABAA receptor is inhibited by the endogenous sulfated steroids pregnenolone sulfate (PS) and dehydroepiandrosterone sulfate (DHEAS). It has been proposed in previous work that these steroids act by enhancing desensitization of the receptor. Here, we have investigated the modulatory effects of the steroids on the human a1b3c2L GABAA receptor. Using electrophysiology and quantitative model-based data analysis, we show that exposure to the steroid promotes occupancy of a nonconducting state that retains high affinity to the transmitter but whose properties differ from those of the classic, transmitter-induced desensitized state. From the analysis of the inhibitory actions of two combined steroids, we infer that PS and DHEAS act through shared or overlapping binding sites.
UR - http://www.scopus.com/inward/record.url?scp=85123812756&partnerID=8YFLogxK
U2 - 10.1124/molpharm.121.000385
DO - 10.1124/molpharm.121.000385
M3 - Article
C2 - 34853153
AN - SCOPUS:85123812756
SN - 0026-895X
VL - 101
SP - 68
EP - 77
JO - Molecular pharmacology
JF - Molecular pharmacology
IS - 2
ER -